Scans show immune cells intercepting parasitesDecember 11, 2008Researchers may have identified one of the body's earliest responses to a group of parasites that causes illness in developing nations. In a paper published online in Public Library of Science Pathogens, scientists report that they tracked immune cells as they patrolled the second-shallowest layer of the skin in an animal model. Injections of a genetically modified form of the parasite Leishmania major caused the immune cells to turn from their patrols and move to intercept the parasites. The same parasites are now infecting U.S. soldiers on patrol in Iraq and Afghanistan, where sand flies, the insects whose bites spread Leishmania, are endemic. The infections normally do not cause symptoms, but the parasite can reactivate and cause complications during pregnancy or if the immune system weakens, including skin sores, fever, damage to the spleen and liver and anemia. "This is one of our most detailed looks so far at how a first responder in the immune system scouts out pathogens," says co-author Stephen Beverley, Ph.D., the Marvin A. Brennecke Professor and head of the Department of Molecular Microbiology at Washington University School of Medicine in St. Louis. "Determining how the immune system reacts is critically important for efforts to develop vaccines that protect against these parasites." According to Beverley, what researchers learn from Leishmania also may have applications for controlling more harmful parasites from the same family of microbes, the trypanosomes. These include Trypanosomiasis, the cause of African sleeping sickness, which disrupts the lymph, circulatory and nervous systems and is fatal if untreated, and Chagas disease, which can damage the heart and the intestine in long-term infections. The study began with an attempt to better understand the role of a group of immune cells known as dendritic cells in the dermis, the second layer of the skin. Scientists at the University of Pennsylvania created a line of mice genetically modified so their dendritic cells produced a yellow fluorescent protein. They used a technique called two-photon microscopy to track the movements of the cells in living mice and show that the cells were "surprisingly motile around the perimeter, moving about and doing all sorts of patrolling," according to Beverley. One of Beverley's graduate students, Michael A. Mandell, took a strain of Leishmania genetically modified to produce red fluorescent protein and injected it into the Pennsylvania group's mice. The different colors allowed them to use two-photon microscopy to track both dendritic cells and parasites at the same time, and they found that the dendritic cells rapidly homed in on the injected parasites. Dendritic cells are antigen-presenting cells, which means they can absorb invaders and then display bits of them on their surface to other immune system cells. This triggers a heightened counterattack against the invaders from a variety of immune cells. Injections of latex beads did not cause the same response from the dendritic cells. "The dendritic cells were clearly recognizing something made by the pathogen that was provoking their response, and that's one question we will be looking to answer in follow-up experiments," Beverley says. Beverley notes that infection with Leishmania and other parasites can cause different diseases in different people, suggesting that genetic differences in parasite and host can alter the immune response. Methods of transmission in the wild are messier than an injection and may also add variety to those responses. "Many of the insects that pass on these parasites are not elegant eaters-they chew on skin, creating pools of many cell types," he explains. "The big question is: How do all the different immune cell types combine to orchestrate the immune system's response? What we've done is to pull out one leading player from that mix, which is an important first step to understanding the overall response." Washington University School of Medicine |
|||||||||||||||||||||
| Related Dendritic Cells Current Events and Dendritic Cells News Articles Sperm may play leading role in spreading HIV Sperm, and not just the fluid it bathes in, can transmit HIV to macrophages, T cells, and dendritic cells (DCs), report a team led by Ana Ceballos at the University of Buenos Aires in Argentina. UBC researchers identify key behavior of immune response to Listeria A team of University of British Columbia microbiologists has identified a key defence mechanism used by the immune system against Listeria with strong implications for the future development of vaccines. Promising new target emerges for autoimmune diseases University of Michigan scientists say they have uncovered a fundamentally new mechanism that holds in check aggressive immune cells that can attack the body's own cells. Scientists learn why even treated genital herpes sores boost the risk of HIV infection New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma Hoag Memorial Hospital Presbyterian today announced promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies. Trojan horse for ovarian cancer -- nanoparticles turn immune system soldiers against tumor cells In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor. Microscopic 'beads' could help create 'designer' immune cells that ignore transplanted organs The future of organ transplantation could include microscopic beads that create "designer" immune cells to help patients tolerate their new organ, Medical College of Georgia researchers say. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. Development of DNA drugs gives hope to lupus patients A generation of DNA-like compounds, class R inhibitory oligonucleotides (INH-ODNs), have been shown to effectively inhibit cells responsible for the chronic autoimmune condition lupus. Team develops DNA compounds that could help treat lupus A research team led by a University of Iowa investigator has generated DNA-like compounds that effectively inhibit the cells responsible for systemic lupus erythematosus -- the most common and serious form of lupus. More Dendritic Cells Current Events and Dendritic Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||